Pages
Products
GFP/Luc Reporter Cell Line - HepG2

GFP/Luc Reporter Cell Line - HepG2

Cat.No. :  CSC-RR0492 Host Cell:  HepG2

Inquire for Price

Cell Line Information

Cell Culture Information

Safety and Packaging

Documents

Cat. No. CSC-RR0492
Description HepG2/GFP-Luc is derived from HepG2 cell line which has been transduced by two lentiviruses, one containing EGFP and puromycin resistance gene, the other containing Firefly luciferase and neomycin resistance gene. HepG2 cell line has been widely used in liver cancer research. This cell line is an ideal tool to support research in both fluorescent and bioluminescent tracing of HepG2 cells.
Gene GFP/Luc
Host Cell HepG2
Host Cell Species Homo sapiens (Human)
Stability Validated for at least 10 passages
Reporter Type Fluorescent protein
Application

1. Gene expression studies

2. Protein localization

3. Drug screening and toxicology

4. Live cell imaging

Quality Control Negative for bacteria, yeast, fungi and mycoplasma.
Shipping Dry ice
Storage Liquid nitrogen
Revival Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media.
Mycoplasma Negative
Format One frozen vial containing millions of cells
Storage Liquid nitrogen
Safety Considerations

The following safety precautions should be observed.

1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum.

2. No eating, drinking or smoking while handling the stable line.

3. Wash hands after handling the stable line and before leaving the lab.

4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells.

5. All waste should be considered hazardous.

6. Dispose of all liquid waste after each experiment and treat with bleach.

Ship Dry ice
Quick Inquiry

Background

Case Study

Applications

Publications

Q & A

Customer Reviews

The GFP/Luc Reporter Cell Line - HepG2 is a dual-reporter cell model that combines the use of both green fluorescent protein (GFP) and luciferase (Luc) as reporters. This cell line is derived from the HepG2 cell line, which is a human hepatocellular carcinoma cell line widely used in cancer research and for the study of liver cancer biology. The simultaneous expression of GFP and luciferase allows for the visualization of cellular processes and the quantification of gene expression, providing a comprehensive tool for studying the effects of various treatments on cancer cells. The HepG2 cell line, with its stable expression of both GFP and luciferase, is particularly useful for high-throughput screening and for investigating the molecular mechanisms underlying liver cancer progression. This dual-reporter system enables researchers to monitor changes in both cell behavior and gene expression in response to potential therapeutic agents, providing valuable insights into the development of targeted cancer therapies.

Oncolytic adenoviruses, particularly type 5 (Ad5), have emerged as promising agents in cancer therapy. However, their effectiveness is often hampered by the presence of neutralizing antibodies and reduced receptor expression on many tumor types. Recent studies have explored alternative adenovirus types, specifically species D, which have shown enhanced transduction and cytotoxicity in various cancer cell lines, including HepG2. Researchers evaluated the oncolytic potential of replication-competent species D adenoviruses engineered to express a GFP-Luciferase reporter, revealing that these vectors could effectively transduce HepG2 cells. This ability to deliver therapeutic genes makes them a valuable tool for studying gene expression and cellular responses in cancer research.

Figure 1 illustrates the viral transduction efficiency of recombinant species D adenoviruses and Ad5 GFP-Luc viruses in infected cells, quantified by the percentage of GFP-positive cells 24 hours post-infection, with statistical analysis from three independent experiments. (doi: 10.3390/v12121399)Figure 1. The researchers infected cells with 500vp/cell of Ad-GFP-Luc viruses, analyzing GFP+ cells 24 hours later using flow cytometry for transduction assessment. (Bullard BL, et al., 2020)

Creative Biogene's GFP/Luc Reporter Cell Line - HepG2 provides a robust platform for researchers interested in exploring gene expression and the efficacy of oncolytic therapies. This cell line can facilitate studies of viral transduction efficiency and gene expression modulation in hepatocellular carcinoma models, mirroring the functionality demonstrated in recent adenoviral research.

The GFP/Luc Reporter Cell Line - HepG2 is a hepatocellular carcinoma cell line that co-expresses green fluorescent protein (GFP) and luciferase. This dual reporter system provides a versatile platform for studying gene expression, cellular processes, and drug responses in liver cancer. (1)Gene Expression and Regulation Studies: The HepG2 GFP/Luc Reporter Cell Line can be used to investigate the regulation of gene expression in response to various stimuli, such as cytokines or small molecule inhibitors. The dual reporters allow for the simultaneous monitoring of two different cellular responses, providing a comprehensive understanding of gene regulation mechanisms. (2)Drug Screening and Toxicity Assessment: The cell line is well-suited for high-throughput screening assays to identify novel compounds that modulate gene expression or protein activity. The ability to measure both GFP and luciferase activity simultaneously enables researchers to quickly assess the effects of numerous compounds, accelerating the discovery of potential therapeutic agents. (3)In Vivo Imaging and Cancer Research: The HepG2 GFP/Luc Reporter Cell Line is valuable for in vivo imaging studies, where the bioluminescent and fluorescent signals can be used to track tumor growth and metastasis in animal models. This capability is crucial for understanding cancer progression and evaluating the effectiveness of cancer therapies.
Customer Q&As
What are the applications of the GFP/Luc Reporter Cell Line - HepG2 in studying hepatocellular carcinoma progression?

A: The GFP/Luc Reporter Cell Line - HepG2 can be utilized in various applications for studying hepatocellular carcinoma progression. Firstly, it allows for the visualization of HepG2 cells in vitro and in vivo through GFP fluorescence, aiding in tracking tumor growth and metastasis. Secondly, the luciferase reporter enables quantitative assessment of tumor progression and response to treatments using bioluminescence assays.

How does the GFP/Luc Reporter Cell Line - HepG2 contribute to drug screening studies targeting liver cancer?

A: In drug screening studies targeting liver cancer, the GFP/Luc Reporter Cell Line - HepG2 provides a valuable tool for evaluating the efficacy of potential therapeutics. Researchers can monitor changes in GFP fluorescence and luciferase activity as indicators of drug response, allowing for high-throughput screening of candidate compounds and identification of promising leads for further investigation.

What are the advantages of using the GFP/Luc Reporter Cell Line - HepG2 compared to conventional cell lines for studying liver biology?

A: The GFP/Luc Reporter Cell Line - HepG2 offers several advantages over conventional cell lines in studying liver biology. Firstly, its stable expression of GFP and luciferase allows for real-time monitoring of cellular processes and responses to stimuli. Secondly, the HepG2 cell line, derived from hepatocellular carcinoma, retains characteristics of liver cells, making it a relevant model for studying liver diseases and drug metabolism.

How can the GFP/Luc Reporter Cell Line - HepG2 facilitate investigations into the role of the tumor microenvironment in hepatocellular carcinoma progression?

A: By utilizing the GFP/Luc Reporter Cell Line - HepG2 in co-culture experiments with stromal cells or immune cells, researchers can elucidate the influence of the tumor microenvironment on hepatocellular carcinoma progression. The GFP fluorescence allows for tracking of HepG2 cells, while luciferase activity enables quantification of changes in tumor growth and response to microenvironmental factors or therapeutic interventions.

Could you explain the process of establishing stable cell lines using the GFP/Luc Reporter Cell Line - HepG2?

A: Establishing stable cell lines with the GFP/Luc Reporter Cell Line - HepG2 involves transfecting HepG2 cells with plasmids containing the GFP and luciferase genes, followed by selection with antibiotics or selection markers. Single-cell cloning can be performed to isolate individual clones with stable expression of both reporters. These clones can then be expanded and characterized for their GFP fluorescence and luciferase activity prior to experimental use.

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Dual-reporter versatility

The GFP/Luc Reporter Cell Line - HepG2 allows simultaneous visualization and quantification of cellular events, providing a dual-reporter system that enhances the depth and breadth of biological assays.

Germany

10/21/2022

Hepatic cell line relevance

HepG2 cells are derived from liver tissue, making the GFP/Luc Reporter Cell Line - HepG2 particularly relevant for liver-related research, such as metabolism studies and hepatotoxicity assays.

French

06/19/2022

Immediate visual confirmation

GFP provides immediate visual confirmation of transfection efficiency and gene expression, streamlining the workflow for the GFP/Luc Reporter Cell Line - HepG2 and reducing the time to results.

French

03/26/2022

Bioluminescence quantification

The luciferase aspect of the GFP/Luc Reporter Cell Line - HepG2 offers highly sensitive bioluminescence quantification, which is ideal for detecting and measuring promoter activity and gene regulation.

Canada

08/12/2020

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction